Patents by Inventor Chris Imray

Chris Imray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and devices to detect stroke in a subject
    Patent number: 10907189
    Abstract: The invention describes a method of determining the presence of acute cerebral ischaemic disorder in a subject comprising: a. measuring the concentration of one or more purines in a body fluid of the subject, the purines being selected from adenosine, inosine, hypoxanthine, xanthine and ATP, and b. comparing the measured concentration with a threshold concentration of the one or more purines, wherein the threshold concentration is preferably in the range 5 ?M to 15 ?M and wherein a measured concentration higher than the threshold concentration indicates the presence of acute ischaemic disorder. Also is described a method of determining the absence of an acute cerebral disorder in a subject comprising: a. measuring the concentration of one or more purines in a body fluid of the subject, the purines being selected from adenosine, inosine, hypoxanthine, xanthine and ATP, and b.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: February 2, 2021
    Assignee: SARISSA BIOMEDICAL LIMITED
    Inventors: Nicholas Dale, Chris Imray, Faming Tian
  • Methods and devices to detect the presence of a condition associated with ATP depletion in a subject
    Patent number: 10889846
    Abstract: The invention provides a method of determining a predisposition to a condition associated with ATP depletion, such as an ischaemic event, in a subject comprising: a. measuring the concentration of one or more purines in a body fluid of the subject, the purines being selected from adenosine, inosine, hypoxanthine, xanthine and ATP, and b. comparing the measured concentration with a threshold concentration of the one or more purines, wherein the threshold concentration is preferably in the range 2 [micro]M to 8 [micro]M and wherein a measured concentration higher than the threshold concentration indicates the presence of ischaemia.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: January 12, 2021
    Assignee: SARISSA BIOMEDICAL LIMITED
    Inventors: Nicholas Dale, Chris Imray, Bruno Frenguelli
  • METHODS AND DEVICES TO DETECT STROKE IN A SUBJECT
    Publication number: 20180163245
    Abstract: The invention describes a method of determining the presence of acute cerebral ischaemic disorder in a subject comprising: a. measuring the concentration of one or more purines in a body fluid of the subject, the purines being selected from adenosine, inosine, hypoxanthine, xanthine and ATP, and b. comparing the measured concentration with a threshold concentration of the one or more purines, wherein the threshold concentration is preferably in the range 5 ?M to 15 ?M and wherein a measured concentration higher than the threshold concentration indicates the presence of acute ischaemic disorder. Also is described a method of determining the absence of an acute cerebral disorder in a subject comprising: a. measuring the concentration of one or more purines in a body fluid of the subject, the purines being selected from adenosine, inosine, hypoxanthine, xanthine and ATP, and b.
    Type: Application
    Filed: June 3, 2016
    Publication date: June 14, 2018
    Inventors: Nicholas Dale, Chris Imray, Faming TIAN
  • METHODS AND DEVICES TO DETECT THE PRESENCE OF A CONDITION ASSOCIATED WITH ATP DEPLETION IN A SUBJECT
    Publication number: 20180155754
    Abstract: The invention provides a method of determining a predisposition to a condition associated with ATP depletion, such as an ischaemic event, in a subject comprising: a. measuring the concentration of one or more purines in a body fluid of the subject, the purines being selected from adenosine, inosine, hypoxanthine, xanthine and ATP, and b. comparing the measured concentration with a threshold concentration of the one or more purines, wherein the threshold concentration is preferably in the range 2 [micro]M to 8 [micro]M and wherein a measured concentration higher than the threshold concentration indicates the presence of ischaemia.
    Type: Application
    Filed: June 3, 2016
    Publication date: June 7, 2018
    Inventors: Nicholas Dale, Chris Imray, Bruno Frenguelli